Taxifolin also alleviates inflammatory responses induced by caspase-1 activation in steatotic hepatocytes, inhibiting lipid accumulation and caspase-1-associated pyroptosis, and demonstrates therapeutic effects on alcohol- and HFD-induced fatty liver [46]. Here, CASP1 is linked to Hepatic steatosis.